Adiponectin Enhances Insulin Sensitivity by Increasing Hepatic IRS-2 Expression via a Macrophage-Derived IL-6-Dependent Pathway

作者：Awazawa Motoharu; Ueki Kohjiro^*; Inabe Kazunori; Yamauchi Toshimasa; Kubota Naoto; Kaneko Kazuma; Kobayashi Masatoshi; Iwane Aya; Sasako Takayoshi; Okazaki Yukiko; Ohsugi Mitsuru; Takamoto Iseki; Yamashita Satoshi; Asahara Hiroshi; Akira Shizuo; Kasuga Masato; Kadowaki Takashi

来源：Cell Metabolism, 2011, 13(4): 401-412.

DOI：10.1016/j.cmet.2011.02.010

Insulin resistance is often associated with impeded insulin signaling due either to decreased concentrations or functional modifications of crucial signaling molecules including insulin receptor substrates (IRS) in the liver. Many actions of adiponectin, a well-recognized antidiabetic adipokine, are currently attributed to the activation of two critical molecules downstream of AdipoR1 and R2: AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR alpha). However, the direct effects of adiponectin on insulin signaling molecules remain poorly understood. We show here that adiponectin upregulates IRS-2 through activation of signal transducer and activator of transcription-3 (STAT3). Surprisingly, this activation is associated with IL-6 production from macrophages induced by adiponectin through NF kappa B activation independent of its authentic receptors, AdipoR1 and AdipoR2. These data have unraveled an insulin-sensitizing action initiated by adiponectin leading to upregulation of hepatic IRS-2 via an IL-6 dependent pathway through a still unidentified adiponectin receptor.

• 出版日期2011-4-6